Exhibit 10.5


 


EXECUTION VERSION


 


SUBSCRIPTION AGREEMENT


 


This Subscription Agreement
is entered into and dated as of December 2, 2021 (this “Agreement”), by and among American Virtual Cloud Technologies,
Inc., a Delaware corporation with offices located at 1720 Peachtree Street, Suite 629, Atlanta, GA 30309 (the “Company”)
and the Subscribers identified on the Schedule of Subscribers attached hereto (each, a “Subscriber” and, together,
the “Subscribers”). Capitalized terms not defined below shall have the meaning as set forth in Section 1.1.


 


RECITALS


 


A. The
Company and each Subscriber is executing and delivering this Agreement in reliance upon the exemption from securities registration afforded
by Section 4(a)(2) of the Securities Act of 1933, as amended (together with the rules and regulations promulgated thereunder, the “1933
Act”), and Rule 506 of Regulation D (“Regulation D”) as promulgated by the United States Securities and
Exchange Commission (the “SEC”) under the 1933 Act.


 


B. The
Company is a borrower under that certain Financing Agreement, dated as of the date hereof, by and among the Company, as borrower, the
lenders from time to time party thereto, and Monroe Capital Management Advisors, LLC (“Monroe”), as administrative agent
for the lenders thereunder (as amended, amended and restated, supplemented or otherwise modified from time to time, the “Financing
Agreement”).


 


C. To
induce the Subscribers (or Affiliates thereof) to enter into the Financing Agreement, the Company wishes to issue, upon the terms and
conditions stated in this Agreement, a warrant to acquire up to that aggregate number of shares of Common Stock set forth opposite such
Subscriber’s name in column (3) on the Schedule of Subscribers, in the form attached hereto as Exhibit A (the “Warrants”)
(as exercised, collectively, the “Warrant Shares”), subject to adjustment as described in the Warrants.


 


D. Contemporaneously
with the execution and delivery of this Agreement, the parties hereto are executing and delivering a Registration Rights Agreement, in
the form attached hereto as Exhibit B (the “Registration Rights Agreement”), pursuant to which the Company has
agreed to provide certain registration rights with respect to the Registrable Securities (as defined in the Registration Rights Agreement)
under the 1933 Act and the rules and regulations promulgated thereunder, and applicable state securities laws.


 


E. The
Warrants and the Warrant Shares are collectively referred to herein as the “Securities.”


 






     


     


    

 


NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which
are hereby acknowledged, the Company and each Subscriber, severally and not jointly, agree as follows:


 


ARTICLE
I.

DEFINITIONS


 


1.1 Definitions.
In addition to the terms defined elsewhere in this Agreement, the following terms shall have the meanings set forth in this Section 1.1:


 


“1934 Act”
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.


 


“Affiliate”
shall have the meaning ascribed to such term in Rule 405 of the 1933 Act.


 


“Business Day”
means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by
law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to “stay at home”, “shelter-in-place”, “non-essential employee” or any other
similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long
as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York, New York generally
are open for use by customers on such day.


 


“Common Stock”
means (i) the Company’s shares of Common Stock, par value $0.0001 per share, and (ii) any share capital into which such Common Stock shall
have been changed or any share capital resulting from a reclassification, reorganization or recapitalization of such Common Stock.


 


“Designee”
means Monroe.


 


“Eligible Market”
means the Principal Market, the NYSE American, The Nasdaq Global Select Market, The Nasdaq Global Market or The New York Stock Exchange,
Inc., or any successor to any of the foregoing.


 


“Governmental Authority”
shall mean any: (a) nation, state, commonwealth, province, territory, county, municipality, district or other jurisdiction of any nature;
(b) federal, state, provincial, local, municipal, foreign or other government; (c) governmental or quasi-governmental authority of any
nature (including any governmental division, department, agency, commission, commissioner, bureau, tribunal, instrumentality, official,
ministry, fund, foundation, center, organization, board, unit, body or Person and any court or other tribunal); or (d) regulatory or self-regulatory
organization (including the Principal Market or other applicable Eligible Market).


 


“Insolvent”
means, (i) with respect to the Company and its Subsidiaries, on a consolidated basis, (A) the present fair saleable value of the Company’s
and its Subsidiaries’ assets is less than the amount required to pay the Company’s and its Subsidiaries’ total Indebtedness (as defined
below), (B) the Company and its Subsidiaries are unable to pay their debts and liabilities, subordinated, contingent or otherwise, as
such debts and liabilities become absolute and matured or (C) the Company and its Subsidiaries intend to incur or believe that they will
incur debts that would be beyond their ability to pay as such debts mature; and (ii) with respect to the Company and each Subsidiary,
individually, (A) the present fair saleable value of the Company’s or such Subsidiary’s (as the case may be) assets is less than the amount
required to pay its respective total Indebtedness, (B) the Company or such Subsidiary (as the case may be) is unable to pay its respective
debts and liabilities, subordinated, contingent or otherwise, as such debts and liabilities become absolute and matured or (C) the Company
or such Subsidiary (as the case may be) intends to incur or believes that it will incur debts that would be beyond its respective ability
to pay as such debts mature.


 






    2


     


    

 


“Lien” means
any mortgage, deed of trust, lien, charge, claim, encumbrance, security interest, right of first refusal, preemptive right or other restrictions
of any kind.


 


“Person” means
an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.


 


“Principal Market”
means The Nasdaq Capital Market.


 


“Proceeding”
means an action, claim, suit, inquiry, investigation or proceeding (including, without limitation, an investigation or partial proceeding,
such as a deposition), whether commenced or, to the Company’s knowledge, threatened in writing.


 


“Required Holders”
means the holders of Warrants representing at least a majority of the number of shares of Common Stock issuable upon exercise of the Warrants
then outstanding (without taking into account any limitations on the exercise of the Warrants set forth therein) and shall include the
Designee so long as the Designee or any of its Affiliates holds any Warrants.


 


“SEC Reports”
shall mean all reports, schedules, forms, applications and other documents, together with any amendments required to be made with respect
thereto, required to be filed by the Company under the 1933 Act and the 1934 Act, including pursuant to Section 13(a) or 15(d) thereof,
for the two (2) years preceding the date hereof.


 


“Subsidiary”
has the meaning as set forth in the Financing Agreement.


 


“Trading Day”
means any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal trading market
for the Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then traded; provided
that “Trading Day” shall not include any day on which the Common Stock is scheduled to trade on such exchange or market for
less than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading on such exchange or market
(or if such exchange or market does not designate in advance the closing time of trading on such exchange or market, then during the hour
ending at 4:00:00 p.m., New York time).


 


“Transaction Documents”
means this Agreement, the Warrants, the Registration Rights Agreement and any other documents, certificates or agreements executed or
delivered in connection with the transactions contemplated hereby.


 


ARTICLE
II.

PURCHASE AND SALE


 


2.1 Purchase
and Sale of the Securities. Subject to the terms and conditions of this Agreement, each Subscriber agrees, severally and not jointly,
to purchase from the Company, and the Company agrees to sell and issue to each Subscriber, at the Closing, such Warrants to acquire up
to that aggregate number of Warrant Shares as is set forth opposite such Subscriber’s name in column (3) on the Schedule of Subscribers.


 


2.2 Closing.
The issuance of the Warrants pursuant to the terms of this Agreement (the “Closing”) shall take place at the offices
of Schulte Roth & Zabel LLP, 919 Third Avenue, New York, NY 10022, at 10:00 a.m. (New York City time) on the date hereof, or at such
other time and place as the Company and the Subscribers mutually agree upon in writing (the “Closing Date”). The Closing
may also be undertaken remotely by electronic transfer of Closing documentation. On the Closing Date, the Company shall deliver to each
Subscriber a Warrant pursuant to which such Subscriber shall have the right to acquire up to such aggregate number of Warrant Shares as
is set forth opposite such Subscriber’s name in column (3) of the Schedule of Subscribers, duly executed on behalf of the
Company and registered in the name of such Subscriber or its designee.


 






    3


     


    

 


2.3 Tax
Matters. To the extent that the parties ascribe a value to the Warrants, for U.S. federal income tax purposes, the parties agree to
treat the Warrants as being issued in exchange for the Subscriber’s commitment to extend the loans pursuant to the Financing Agreement
and the parties agree to amortize the value ascribed to the Warrants over the term of the Financing Agreement in a manner comparable to
the amortization of original issue discount.


 


ARTICLE
III.

REPRESENTATIONS AND WARRANTIES


 


3.1 Representations
and Warranties of the Company. The Company hereby represents and warrants as of the date hereof and as of the Closing Date (except
for representations and warranties that speak as of a specific date, which shall be made as of such date) to each of the Subscribers,
except as set forth in the Schedules delivered herewith:


 


(a) Authorization;
Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by each of the Transaction Documents and otherwise to carry out its respective obligations hereunder and thereunder. Other than the Required
Approvals (as defined in Section 3.1(c)), the execution and delivery by the Company of each of the Transaction Documents and the
consummation by it of the transactions contemplated hereunder and thereunder have been duly authorized by all necessary action on the
part of the Company and no further consent or action is required by the Company, or its board of directors or shareholders. Each Transaction
Document has been (or upon delivery will have been) duly executed by the Company, and, when delivered in accordance with the terms hereof,
will constitute the valid and binding obligation of the Company, enforceable against the Company, in accordance with its terms, except
as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation or similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies and except
as rights to indemnification and to contribution may be limited by federal or state securities law.


 


(b) No
Conflicts. The execution, delivery and performance of the Transaction Documents by the Company and the consummation by the Company
of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Warrants and the Warrant Shares
and the reservation for issuance of the Warrant Shares) do not and will not (x) conflict with or violate any provision of the Company’s
or any Subsidiary’s certificate or articles of incorporation, bylaws or other organizational or charter documents, (y) conflict with,
or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of
any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected (other than any such conflict, default or other right
that has been validly waived), or (z) result in a violation of any law, rule, regulation, order, judgment, injunction, decree or
other restriction of any Governmental Authority to which the Company or a Subsidiary is subject (including, without limitation, foreign,
federal and state securities laws and regulations and the rules and regulations of the Principal Market), or by which any property or
asset of the Company or a Subsidiary is bound or affected; except in the case of clause (y) or (z) above, as would not, reasonably be
expected to, (i) result in a material adverse effect, in or affect the transactions contemplated hereby or the other Transaction Documents,
(ii) adversely affect the legality, validity, binding effect or enforceability of any Transaction Document, (iii) have or result
in a material adverse effect on the operations, properties, results of operations, assets, business, liabilities or condition (financial
or otherwise) of the Company and the Subsidiaries, individually or taken as a whole, or (iv) adversely impair the Company’s authority
or ability to perform fully on a timely basis its obligations under any Transaction Document (any of (i), (ii), (iii) or (iv), a “Material
Adverse Effect”).


 






    4


     


    

 


(c) Filings,
Consents and Approvals. Neither the Company nor any Subsidiary is required to obtain any consent, waiver, authorization, permit or
order of, give any notice to, or make any filing or registration with, any Governmental Authority or other Person in connection with the
execution, delivery and performance by the Company of the Transaction Documents, other than the filing by the Company of a Notice of Sale
of Securities on Form D with the SEC under Regulation D and state and applicable Blue Sky filings (collectively, the “Required
Approvals”). All Required Approvals have been obtained or effected on or prior to the Closing Date or will be made timely after
the Closing Date, and neither the Company nor any Subsidiary are aware of any facts or circumstances which might prevent the Company or
any Subsidiary from obtaining or effecting any of the registration, application or filings contemplated by the Transaction Documents.
The Company is not in violation of the requirements of the Principal Market and has no knowledge of any facts or circumstances which would
reasonably be expected to result in the delisting or suspension of the Common Stock in the foreseeable future.


 


(d) Issuance
of the Securities. The issuance of the Warrants is duly authorized and, upon issuance in accordance with the terms of the Transaction
Documents, will be validly issued, fully paid and non-assessable and free from all preemptive or similar rights (other than any such rights
that have been validly waived), taxes, Liens and charges with respect to the issue thereof and will constitute valid and legally binding
obligations of the Company. As of the Closing, the Company shall have reserved from its duly authorized capital stock not less than the
maximum number of Warrant Shares issuable upon exercise of the Warrants (without taking into account any limitations on the exercise of
the Warrants set forth therein). Upon exercise in accordance with the Warrants, the Warrant Shares when issued, will be validly issued,
fully paid and nonassessable and free from all preemptive or similar rights, taxes, Liens and charges with respect to the issue thereof,
with the holders being entitled to all rights accorded to a holder of Common Stock (as set forth in the applicable charter documents).
Subject to the accuracy of the representations and warranties of the Subscribers in this Agreement, the offer and issuance by the Company
of the Securities is exempt from registration under the 1933 Act.


 


(e) Capitalization.
The number of shares and type of all authorized, issued and outstanding capital stock of the Company has been set forth in the SEC Reports
and has changed since the date set forth in the most recent applicable SEC Report only to reflect exercises of stock options and other
convertible securities that have not been required to be reported by the Company under the 1934 Act. Without limiting the foregoing, as
of the date hereof, immediately prior to (A) the issuance of the Warrants, (B) the adjustment to the number of shares of Common Stock
issuable upon exercise of the Series A Warrant to Purchase Common Stock and Series B Warrant to Purchase Common Stock, and the issuance
of a new Series C Warrant to Purchase Common Stock, in each pursuant to an Amendment and Waiver being entered into on or about the date
hereof with the party identified as the “Buyer” in that certain Securities Purchase Agreement filed as Exhibit 10.1 to the
Current Report on Form 8-K filed by the Company on November 3, 2021, the authorized capital stock of the Company consists of (i) 500,000,000
shares of Common Stock, of which 67,957,150 shares are issued and outstanding, 3,695,000 shares are reserved for issuance pursuant to
issued and outstanding restricted stock units or options and 40,385,675 shares are reserved for issuance pursuant to securities (other
than the aforementioned options) exercisable or exchangeable for, or convertible into, shares of Common Stock; and (ii) 5,000,000
shares of preferred stock, par value $0.0001 per share (“Preferred Stock”), none of which is outstanding. Other than
as stated in the immediately preceding sentence, the Company does not have any outstanding securities that are exercisable or exchangeable
for, or convertible into, shares of Common Stock. All of such outstanding shares are duly authorized and have been, or upon issuance will
be, validly issued and are fully paid and nonassessable. No securities of the Company are entitled to preemptive or similar rights, and
no Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions
contemplated by the Transaction Documents, in each case other than any such rights that have been validly waived. There are no securities
or instruments containing anti-dilution or similar provisions that will be triggered by the issuance of the Securities, after giving effect
to any waivers granted with respect to such provisions. The Company does not have any stock appreciation rights, “phantom stock”
plans or agreements or any similar plan or agreement.


 






    5


     


    

 


(f) Certain
Fees. No brokerage or finder’s fees or commissions are or will be payable by the Company to any broker, financial advisor or consultant,
finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by this Agreement. The
Subscribers shall have no obligation with respect to any fees or with respect to any claims (other than such fees or commissions owed
by a Subscriber pursuant to written agreements executed by such Subscriber which fees or commissions shall be the sole responsibility
of such Subscriber, if any) made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due
in connection with the transactions contemplated by this Agreement. The Company shall indemnify and hold harmless the Subscribers, their
employees, officers, directors, agents, and partners, and their respective Affiliates, from and against all claims, losses, damages, costs
(including the costs of preparation and attorney’s fees) and expenses suffered in respect of any such claimed or existing fees, as such
fees and expenses are incurred.


 


(g) Private
Placement; No Integrated Offering; No General Solicitation; No Disqualification Events. Assuming in part the accuracy of each Subscriber’s
representations and warranties set forth in Sections 3.2(c)-(g), (i) no registration under the 1933 Act is required for
the offer and sale of the Securities by the Company to the Subscribers under the Transaction Documents, and (ii) the issuance and sale
of the Securities hereunder does not contravene the rules and regulations of the Principal Market. Assuming in part the accuracy of the
Subscribers’ representations and warranties set forth in Section 3.2, neither the Company, the Subsidiaries, any of their respective
Affiliates, nor any Person acting on their behalf has, directly or indirectly, made any offers or sales of any Company security or solicited
any offers to buy any security, under circumstances that would require registration of the issuance of any of the Securities under the
1933 Act, whether through integration with prior offerings or otherwise or cause this offering of the Securities to require approval of
shareholders of the Company for purposes of the 1933 Act or any applicable shareholder approval provisions, including, without limitation,
under the rules and regulations of any exchange or automated quotation system on which any of the securities of the Company are listed
or designated. Neither the Company, the Subsidiaries nor their Affiliates, nor any Person acting on its or their behalf, has engaged in
any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with the offer or sale of the
Securities. With respect to Securities to be offered and sold hereunder in reliance on Rule 506(b) under the 1933 Act (“Regulation
D Securities”), none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer
of the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company’s outstanding voting equity
securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the 1933 Act) connected
with the Company in any capacity at the time of sale, nor any other Person covered by Rule 506(d) (each, an “Issuer Covered Person”
and, together, “Issuer Covered Persons”) is or has been subject to any of the “Bad Actor” disqualifications
described in Rule 506(d)(1)(i) to (viii) under the 1933 Act (a “Disqualification Event”), except for a Disqualification
Event covered by Rule 506(d)(2) or (d)(3). The Company has determined that no Issuer Covered Person is subject to a Disqualification Event.
The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Subscribers
a copy of any disclosures provided thereunder. No Person has been or will be paid (directly or indirectly) remuneration for solicitation
of Subscribers or potential purchasers in connection with the sale of any Regulation D Securities. The Company is not aware of any Person
that has been or will be paid (directly or indirectly) remuneration for solicitation of Buyers or potential purchasers in connection with
the sale of any Regulation D Securities.


 


(h) Application
of Takeover Protections. The Company and its Board of Directors have taken all necessary action, if any, in order to render inapplicable
any control share acquisition, interested shareholder, business combination, poison pill (including any distribution under a rights agreement,
or similar arrangement or plan) or other similar anti-takeover provision under the Company’s certificate or articles of incorporation,
bylaws or other organizational or charter documents or the laws of its jurisdiction of incorporation that is or could become applicable
to the Subscribers as a result of the Subscribers and the Company fulfilling their obligations or exercising their rights under the Transaction
Documents, including without limitation as a result of the Company’s issuance of the Securities and the Subscribers’ ownership of the
Securities. The Company and its Board of Directors have taken all necessary action, if any, in order to render inapplicable any shareholder
rights plan or similar arrangement relating to accumulations of beneficial ownership of shares of Common Stock or a change in control
of the Company or any Subsidiary.


 


(i) Registration
Eligibility. The Company is eligible to register the Registrable Securities for resale by the Subscribers using Form S-3 promulgated
under the 1933 Act.


 


(j) Transfer
Taxes. On the Closing Date, all stock transfer or other taxes (other than income or similar taxes) which are required to be paid in
connection with the sale and transfer of the Securities to be sold to each Subscriber hereunder will be, or will have been, fully paid
or provided for by the Company, and all laws imposing such taxes will be or will have been complied with.



 






    6


     


    

 


(k) Shell
Company Status. The Company is not, and has not been since April 7, 2020, an issuer identified in Rule 144(i)(1)(i) of the 1933 Act.
As of April 14, 2020, the Company filed current “Form 10 information” (as defined in Rule 144 (i)(3)) with the SEC reflecting
its status as an entity that was no longer an issuer described in Rule 144(i)(1)(i).


 


(l) Investment
Company Status. Neither the Company nor any Subsidiary is, and upon consummation of the sale of the Securities, and for so long any
Subscriber holds any Securities, will be, an “investment company,” a company controlled by an “investment company”
or an “affiliated person” of, or “promoter” or “principal underwriter” for, an “investment company”
as such terms are defined in the Investment Company Act of 1940, as amended.


 


(m) U.S.
Real Property Holding Corporation. The Company is not, has never been, and so long as any Securities remain outstanding, shall not
become, a U.S. real property holding corporation within the meaning of Section 897 of the Code and the Company shall so certify upon any
Subscriber’s request.


 


(n) Bank
Holding Company Act. Neither the Company nor any of its Subsidiaries is subject to the Bank Holding Company Act of 1956, as amended
(the “BHCA”) and to regulation by the Board of Governors of the Federal Reserve System (the “Federal Reserve”).
Neither the Company nor any of its Subsidiaries or affiliates owns or controls, directly or indirectly, five percent (5%) or more of the
outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity
that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or affiliates exercises
a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal
Reserve.


 


(o) Loan
Documents. The Company hereby acknowledges and agrees that each of the Transaction Documents constitutes a “Loan Document”
under the Financing Agreement. Accordingly, it shall be an Event of Default under the Financing Agreement if (i) any representation
or warranty made by the Company under or in connection with any Transaction Document shall have been untrue, false or misleading in any
material respect when made, or (ii) the Company shall fail to perform or observe any term, covenant or agreement contained in any
Transaction Document.


 


(p) SEC
Documents; Financial Statements. Except as set forth in Schedule 3.1(p), during the two (2) years prior to the date hereof,
the Company has timely filed all reports, schedules, forms, proxy statements, statements and other documents required to be filed by it
with the SEC pursuant to the reporting requirements under Section 13(a) or 15(d) of the 1934 Act (all of the foregoing filed prior to
the date hereof and all exhibits and appendices included therein and financial statements, notes and schedules thereto and documents incorporated
by reference therein being hereinafter referred to as the “SEC Documents”), or has received a valid extension of such
time of filing and has filed any such SEC Documents prior to the expiration of any such extension, except to the extent such extension
has not yet expired. Except as disclosed in the SEC Documents, as of their respective dates, the SEC Documents complied in all material
respects with the requirements of the 1934 Act and the rules and regulations of the SEC promulgated thereunder applicable to the SEC Documents,
and none of the SEC Documents, at the time they were filed with the SEC, contained any untrue statement of a material fact or omitted
to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading. Except as disclosed in the SEC Documents, as of their respective dates, the financial statements
of the Company included in the SEC Documents complied in all material respects with applicable accounting requirements and the published
rules and regulations of the SEC with respect thereto as in effect as of the time of filing. Except as disclosed in the SEC Documents,
such financial statements have been prepared in accordance with generally accepted accounting principles, consistently applied during
the periods involved (“GAAP”) (except (i) as may be otherwise indicated in such financial statements or the notes thereto,
or (ii) in the case of unaudited interim statements, to the extent they may exclude footnotes or may be condensed or summary statements)
and fairly present in all material respects the financial position of the Company as of the dates thereof and the results of its operations
and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments which will
not be material, either individually or in the aggregate). The reserves, if any, established by the Company or the lack of reserves, if
applicable, are reasonable based upon facts and circumstances known by the Company on the date hereof and there are no loss contingencies
that are required to be accrued by the Statement of Financial Accounting Standard No. 5 of the Financial Accounting Standards Board which
are not provided for by the Company in its financial statements or otherwise. No other information provided by or on behalf of the Company
to any of the Buyers which is not included in the SEC Documents (including, without limitation, information referred to in Section 3.2(g)
of this Agreement or in the disclosure schedules to this Agreement) contains any untrue statement of a material fact or omits to state
any material fact necessary in order to make the statements therein, in the light of the circumstance under which they are or were made,
not misleading. Except as disclosed in the SEC Documents, the Company is not currently contemplating to amend or restate any of the financial
statements (including, without limitation, any notes or any letter of the independent accountants of the Company with respect thereto)
included in the SEC Documents (the “Financial Statements”), nor is the Company currently aware of facts or circumstances
which would require the Company to amend or restate any of the Financial Statements, in each case, in order for any of the Financials
Statements to be in compliance with GAAP and the rules and regulations of the SEC. Except as disclosed in the SEC Documents, the Company
has not been informed by its independent accountants that they recommend that the Company amend or restate any of the Financial Statements
or that there is any need for the Company to amend or restate any of the Financial Statements.


 






    7


     


    

 


(q) Internal
Accounting and Disclosure Controls. Except as disclosed in the SEC Documents, the Company and each of its Subsidiaries maintains internal
control over financial reporting (as such term is defined in Rule 13a-15(f) under the 1934 Act) that is effective to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
with GAAP, including that (i) transactions are executed in accordance with management’s general or specific authorizations,
(ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset
and liability accountability, (iii) access to assets or incurrence of liabilities is permitted only in accordance with management’s
general or specific authorization and (iv) the recorded accountability for assets and liabilities is compared with the existing assets
and liabilities at reasonable intervals and appropriate action is taken with respect to any difference. The Company maintains disclosure
controls and procedures (as such term is defined in Rule 13a-15(e) under the 1934 Act) that are effective in ensuring that information
required to be disclosed by the Company in the reports that it files or submits under the 1934 Act is recorded, processed, summarized
and reported, within the time periods specified in the rules and forms of the SEC, including, without limitation, controls and procedures
designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the 1934 Act
is accumulated and communicated to the Company’s management, including its principal executive officer or officers and its principal
financial officer or officers, as appropriate, to allow timely decisions regarding required disclosure. Neither the Company nor any of
its Subsidiaries has received any notice or correspondence from any accountant, Governmental Authority or other Person relating to any
potential material weakness or significant deficiency in any part of the internal controls over financial reporting of the Company or
any of its Subsidiaries.


 


(r) Sarbanes-Oxley
Act. The Company and each Subsidiary is in compliance with any and all applicable requirements of the Sarbanes-Oxley Act of 2002,
as amended, and any and all applicable rules and regulations promulgated by the SEC thereunder.


 


(s) Acknowledgement
Regarding Subscribers’ Trading Activity. It is understood and acknowledged by the Company that (i) following the public disclosure
of the transactions contemplated by the Transaction Documents, in accordance with the terms thereof, none of the Subscribers have been
asked by the Company or any of its Subsidiaries to agree, nor has any Subscriber agreed with the Company or any of its Subsidiaries, to
desist from effecting any transactions in or with respect to (including, without limitation, purchasing or selling, long and/or short)
any securities of the Company, or “derivative” securities based on securities issued by the Company or to hold any of the Securities
for any specified term; (ii) any Subscriber, and counterparties in “derivative” transactions to which any such Subscriber is
a party, directly or indirectly, presently may have a “short” position in the Common Stock which was established prior to such
Subscriber’s knowledge of the transactions contemplated by the Transaction Documents; and (iii) each Subscriber shall not be deemed to
have any affiliation with or control over any arm’s length counterparty in any “derivative” transaction. The Company further
understands and acknowledges that following the public disclosure of the transactions contemplated by the Transaction Documents one or
more Subscribers may engage in hedging and/or trading activities (including, without limitation, the location and/or reservation of borrowable
shares of Common Stock) at various times during the period that the Securities are outstanding, and such hedging and/or trading activities
(including, without limitation, the location and/or reservation of borrowable shares of Common Stock), if any, can reduce the value of
the existing shareholders’ equity interest in the Company both at and after the time the hedging and/or trading activities are being conducted.
The Company acknowledges that such aforementioned hedging and/or trading activities do not constitute a breach of this Agreement or any
other Transaction Document.


 






    8


     


    

 


(t) Manipulation
of Price. Neither the Company nor any of its Subsidiaries has, and, to the knowledge of the Company, no Person acting on their behalf
has, directly or indirectly, (i) taken any action designed to cause or to result in the stabilization or manipulation of the price of
any security of the Company or any of its Subsidiaries to facilitate the sale of any of the Securities, (ii) sold, bid for, purchased,
or paid any compensation for soliciting purchases of, any of the Securities, (iii) paid or agreed to pay to any Person any compensation
for soliciting another to purchase any other securities of the Company or any of its Subsidiaries or (iv) paid or agreed to pay any Person
for research services with respect to any securities of the Company or any of its Subsidiaries.


 


(u) Absence
of Certain Changes. Except as disclosed in the SEC Documents, since December 31, 2020, there has been no material adverse change and
no material adverse development in the business, assets, liabilities, properties, operations (including results thereof), condition (financial
or otherwise) or prospects of the Company or any of its Subsidiaries. Since December 31, 2020, neither the Company nor any of its Subsidiaries
has (i) declared or paid any dividends, (ii) sold any assets, individually or in the aggregate, outside of the ordinary course of business
or (iii) made any capital expenditures, individually or in the aggregate, outside of the ordinary course of business. Neither the Company
nor any of its Subsidiaries has taken any steps to seek protection pursuant to any law or statute relating to bankruptcy, insolvency,
reorganization, receivership, liquidation or winding up, nor does the Company or any Subsidiary have any knowledge or reason to believe
that any of their respective creditors intend to initiate involuntary bankruptcy proceedings or any actual knowledge of any fact which
would reasonably lead a creditor to do so. The Company and its Subsidiaries, individually and on a consolidated basis, are not as of the
date hereof, and after giving effect to the transactions contemplated hereby to occur at the Closing, will not be Insolvent. Neither the
Company nor any of its Subsidiaries has engaged in any business or in any transaction, and is not about to engage in any business or in
any transaction, for which the Company’s or such Subsidiary’s remaining assets constitute unreasonably small capital with which to conduct
the business in which it is engaged as such business is now conducted and is proposed to be conducted.


 


(v) Acknowledgment
Regarding Buyer’s Purchase of Securities. The Company acknowledges and agrees that each Subscriber is acting solely in the capacity
of an arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated hereby and thereby and that no
Subscriber is (i) an officer or director of the Company or any of its Subsidiaries, (ii) an “affiliate” (as defined in Rule
144) of the Company or any of its Subsidiaries or (iii) to its knowledge, a “beneficial owner” of more than 10% of the shares
of Common Stock (as defined for purposes of Rule 13d-3 of the 1934 Act). The Company further acknowledges that no Subscriber is acting
as a financial advisor or fiduciary of the Company or any of its Subsidiaries (or in any similar capacity) with respect to the Transaction
Documents and the transactions contemplated hereby and thereby, and any advice given by a Subscriber or any of its representatives or
agents in connection with the Transaction Documents and the transactions contemplated hereby and thereby is merely incidental to such
Subscriber’s acquisition of the Securities. The Company further represents to each Subscriber that the Company’s and each Subsidiary’s
decision to enter into the Transaction Documents to which it is a party has been based solely on the independent evaluation by the Company,
each Subsidiary and their respective representatives.


 


(w) No
Undisclosed Events, Liabilities, Developments or Circumstances. To the Company’s knowledge, other than as disclosed in the SEC
Documents, no event, liability, development or circumstance has occurred or exists, or is reasonably expected to exist or occur with respect
to the Company, any of its Subsidiaries or any of their respective businesses, properties, liabilities, prospects, operations (including
results thereof) or condition (financial or otherwise), that (i) would be required to be disclosed by the Company under applicable securities
laws on a registration statement on Form S-1 filed with the SEC relating to an issuance and sale by the Company of its Common Stock and
which has not been publicly announced, (ii) would reasonably be expected to have a material adverse effect on any Buyer’s investment
hereunder or (iii) would reasonably be expected to have a Material Adverse Effect.


 






    9


     


    

 


3.2 Representations
and Warranties of the Subscribers. Each Subscriber hereby, as to itself only and for no other Subscriber, represents and warrants
as of the date hereof and as of the Closing Date (except for representations and warranties that speak as of a specific date, which shall
be made as of such date) to the Company as follows:


 


(a) Organization;
Authority. Such Subscriber is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction of
its organization with the requisite power and authority to enter into and to consummate the transactions contemplated by the Transaction
Documents and otherwise to carry out its obligations hereunder and thereunder. The execution, delivery and performance by such Subscriber
of the Transaction Documents to which it is a party have been duly authorized by all necessary action on the part of such Subscriber.
Each of the Transaction Documents to which such Subscriber is a party has been duly executed by such Subscriber and, when delivered by
such Subscriber in accordance with terms hereof, will constitute the valid and legally binding obligation of such Subscriber, enforceable
against it in accordance with its terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy,
insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally, the enforcement of applicable
creditors’ rights and remedies.


 


(b) No
Conflicts. The execution, delivery and performance of the Transaction Documents by such Subscriber and the consummation by such Subscriber
of the transactions contemplated hereby and thereby do not and will not (i) conflict with or violate any provision of such Subscriber’s
certificate or articles of incorporation, bylaws or other organizational or charter documents, (ii) conflict with, or constitute a default
(or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment,
acceleration or cancellation of, any agreement, indenture or instrument to which such Subscriber is a party, or (iii) result in a
violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any Governmental Authority to which
such Subscriber is subject (including, without limitation, foreign, federal and state securities laws and regulations); except in the
case of clause (ii) or (iii) above, as would not, reasonably be expected to have, individually or in the aggregate, a material adverse
effect on the ability of the Subscriber to perform its obligations thereunder.


 


(c) Investment
Intent. Such Subscriber is acquiring the Securities as principal for its own account for investment purposes and not with a view
to distributing or reselling such Securities or any part thereof in violation of applicable securities laws, without prejudice,
however, to such Subscriber’s right at all times to sell or otherwise dispose of all or any part of such Securities in compliance
with applicable federal and state securities laws. Nothing contained herein shall be deemed a representation or warranty by such
Subscriber to hold the Securities for any period of time. Such Subscriber understands that the Securities have not been registered
under the 1933 Act, and therefore the Securities may not be sold, assigned or transferred unless pursuant to (i) an effective
registration statement under the 1933 Act with respect thereto or (ii) an available exemption from the registration requirements of
the 1933 Act.


 


(d) Subscriber
Status. At the time such Subscriber was offered the Securities, it was, and at the date hereof it is, and on each date on which it
exercises the Warrants (other than pursuant to a cashless exercise), it will be, an “accredited investor” as defined in Rule
501(a) under the 1933 Act.


 


(e) Experience
of such Subscriber. Such Subscriber, either alone or together with its representatives, has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. Such Subscriber is able to bear the economic risk of an investment in the
Securities and, at the present time, is able to afford a complete loss of such investment.


 






    10


     


    

 


(f) General
Solicitation. Such Subscriber is not purchasing the Securities as a result of any advertisement, article, notice or other communication
regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any
seminar or any other general advertisement or, to such Subscriber’s knowledge, any other general solicitation.


 


(g) Access
to Data. Such Subscriber has received and reviewed information about the Company and has had an opportunity to discuss the Company’s
business, management and financial affairs with its management and to review the Company’s facilities. Such Subscriber acknowledges that
it has been afforded (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives
of the Company concerning the terms and conditions of the offering of the Securities and the merits and risks of investing in the Securities;
(ii) access to information about the Company and its respective financial condition, results of operations, business, properties,
management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional
information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment
decision with respect to the investment. The foregoing, however, does not limit or modify the representations and warranties made by the
Company in this Agreement or the SEC Reports or any other provision in this Agreement or the SEC Reports or the right of the Subscribers
to rely thereon. Such Subscriber has sought such accounting, legal and tax advice as it has considered necessary to make an informed decision
with respect to its acquisition of the Securities.


 


(h) Transfer
or Resale. Such Subscriber understands that except as provided in the Registration Rights Agreement: (i) the Securities have not been
and are not being registered under the 1933 Act or any state securities laws, and may not be offered for sale, sold, assigned or transferred
unless (A) subsequently registered thereunder, (B) such Subscriber shall have delivered to the Company (if requested by the Company) an
opinion of counsel selected by such Subscriber, reasonably satisfactory to the Company as to such counsel and to the form of opinion,
to the effect that such Securities may be sold, assigned or transferred without registration under the applicable requirements of the
1933 Act; provided, however, that Schulte Roth & Zabel LLP shall be deemed reasonably satisfactory to the Company; provided,
further, that no such opinion shall be required to sell, assign or otherwise transfer all or any portion of such Securities to
an Affiliate of the holder of the Securities, or (C) such Subscriber provides the Company with assurance reasonably satisfactory to the
Company that such Securities can be sold, assigned or transferred pursuant to Rule 144 promulgated under the 1933 Act (or a successor
rule thereto) (collectively, “Rule 144”); (ii) any sale of the Securities made in reliance on Rule 144 may be made
only in accordance with the terms of Rule 144; and (iii) neither the Company nor any other Person is under any obligation to register
the Securities under the 1933 Act or any state securities laws or to comply with the terms and conditions of any exemption thereunder.


 


(i) Reliance
on Exemptions. Such Subscriber understands that the Securities being offered and sold to it in reliance on specific exemptions from
the registration requirements of United States federal and state securities laws and that the Company is relying in part upon the truth
and accuracy of, and such Subscriber’s compliance with, the representations, warranties, agreements, acknowledgements and understandings
of such Subscriber set forth herein in order to determine the availability of such exemptions and the eligibility of such Subscriber to
acquire the Securities.


 


(j) No
Governmental Review. Such Subscriber understands that no United States federal or state agency or any other government or governmental
agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the
Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.


 






    11


     


    

 


(k) Legends.
Such Subscriber understands that the certificates or other instruments representing the Warrants and, until such time as the resale of
the Warrant Shares have been registered under the 1933 Act as contemplated by the Registration Rights Agreement, the stock certificates
representing the Warrant Shares, except as set forth below, shall bear a restrictive legend in substantially the following form (and a
stop-transfer order may be placed against transfer of such stock certificates):


 


[NEITHER THE ISSUANCE AND SALE
OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN][THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN] REGISTERED UNDER THE 1933 ACT OF 1933, AS AMENDED, OR APPLICABLE STATE
SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION
STATEMENT FOR THE SECURITIES UNDER THE 1933 ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL SELECTED BY THE HOLDER, REASONABLY SATISFACTORY
TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS ELIGIBLE TO BE SOLD OR SOLD PURSUANT TO RULE 144
OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT
OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.


 


The legend set forth
above shall be removed and the Company shall issue a certificate without such legend to the holder of the Securities upon which it is
stamped or issue to such holder by electronic delivery at the applicable balance account at The Depository Trust Company (“DTC”),
if (i) such Securities are registered for resale under the 1933 Act, (ii) in connection with a sale, assignment or other transfer, such
holder provides the Company with an opinion of counsel, reasonably satisfactory to the Company as to such counsel and to the form of opinion,
to the effect that such sale, assignment or transfer of the Securities may be made without registration under the applicable requirements
of the 1933 Act; provided, however, that Schulte Roth & Zabel LLP shall be deemed reasonably satisfactory to the Company;
provided, further, that no such opinion shall be required to sell, assign or otherwise transfer all or any portion of such
Securities to an Affiliate of the holder of the Securities, or (iii) the Securities can be sold, assigned or transferred pursuant to Rule
144. The Company shall, at its sole expense, cause its counsel to issue a legal opinion to its transfer agent, if required by its transfer
agent or by a holder of the Securities, to effect the removal of the legend hereunder. The Company shall be responsible for the fees of
its transfer agent and all DTC fees associated with such issuance. If the Company shall fail for any reason or for no reason to issue
to the holder of the Securities within two (2) Trading Days after the occurrence of any of (i) through (iii) above (the initial date
of such occurrence, the “Legend Removal Date” and such failure, a “Legend Removal Failure”), a certificate
without such legend to such holder or to issue such Securities to such holder by electronic delivery at the applicable balance account
at DTC, then, in addition to all other remedies available to such holder, the Company shall pay in cash to such holder on each day after
the second (2nd) Trading Day after the Legend Removal Date and during such Legend Removal Failure an amount equal to 1.5% of
the product of (i) the number of shares represented by such certificate and (ii) any trading price of the Common Stock selected by the
holder in writing as in effect at any time during the period beginning on the Legend Removal Date and ending on the date the Company makes
the applicable cash payment, and if on or after such Trading Day the holder purchases (in an open market transaction or otherwise) Common
Stock relating to the applicable Legend Removal Failure (a “Legend Buy-In”), then the Company shall, within two (2) Trading
Days after the holder’s request and in the holder’s discretion, either (i) pay cash to the holder in an amount equal to the holder’s total
purchase price (including brokerage commissions, if any) for the Common Stock so purchased (the “Legend Buy-In Price”),
at which point the obligation of the Company to deliver such unlegended Securities shall terminate, or (ii) promptly honor its obligation
to deliver to the holder such unlegended Securities as provided above and pay cash to the holder in an amount equal to the excess (if
any) of the Legend Buy-In Price over the product of (A) such number of shares of Common Stock, times (B) any trading price of the Common
Stock selected by the Holder in writing as in effect at any time during the period beginning on the applicable Legend Removal Date and
ending on the date the Company makes the applicable cash payment.


 


The Company acknowledges
and agrees that no Subscriber makes or has made any representations or warranties with respect to the transactions contemplated hereby
or by any other Transaction Document other than those specifically set forth in Section 3.2.


 






    12


     


    

 


ARTICLE
IV.

OTHER AGREEMENTS OF THE PARTIES


 


4.1 Register;
Pledge.


 


(a) The
Company shall maintain at its principal executive offices (or such other office or agency of the Company as it may designate by notice
to each holder of Securities), a register for each series of the Warrants in which the Company shall record the name and address of the
Person in whose name the Warrants have been issued (including the name and address of each transferee) the number of Warrant Shares issuable
upon exercise of the Warrants held by such Person. The Company shall keep the register open and available at all times during business
hours for inspection of any Subscriber or its legal representatives.


 


(b) The
Company acknowledges and agrees that a Subscriber may from time to time pledge or grant a security interest in some or all of the Securities
in connection with a bona fide margin agreement secured by the Securities and, if required under the terms of such agreement, such Subscriber
may transfer pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval
of the Company and no legal opinion of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no notice
shall be required of such pledge. At the appropriate Subscriber’s expense, the Company will execute and deliver such reasonable documentation
as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities.


 


4.2 Integration.
The Company shall not, and shall use its reasonable best efforts to ensure that no Affiliate of the Company shall, sell, offer for sale
or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the 1933 Act) that would be
integrated with the offer or sale of the Securities in a manner that would require the registration under the 1933 Act of the sale of
the Securities to the Subscribers or that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations
of the Principal Market.


 


4.3 Reservation
and Listing of Securities. So long as any Subscriber owns any Warrants, the Company shall take all action necessary to at all
times after the date hereof have authorized, and reserved for the purpose of issuance, a number of shares of Common Stock issuable
upon exercise of the Warrants equal to at least 150% of the maximum number of shares of Common Stock as shall be necessary to effect
the exercise in full of all Warrants then outstanding (without taking into account any limitations on the exercise of the Warrants
set forth in the Warrants) (the “Required Reserve Amount”). If at any time the number of shares of Common Stock
authorized and reserved for issuance is not sufficient to meet the Required Reserve Amount, the Company will promptly take all
corporate action necessary to authorize and reserve a sufficient number of shares, including, without limitation, calling a special
meeting of shareholders to authorize additional shares to meet the Company’s obligations under Section 3.1(d) and this Section
4.3, in the case of an insufficient number of authorized shares, obtain shareholder approval of an increase in such authorized
number of shares, and voting the management shares of the Company in favor of an increase in the authorized shares of the Company to
ensure that the number of authorized shares is sufficient to meet the Required Reserve Amount. The Company shall, as applicable (i)
prepare and timely file with the Principal Market an additional shares listing application covering all of the shares of Common
Stock issued or issuable under the Transaction Documents, (ii) use reasonable best efforts to cause such shares of Common Stock
to be approved for listing on the Principal Market as soon as practicable thereafter, (iii) provide to the Subscribers evidence
of such listing, and (iv) use reasonable best efforts to maintain the listing of such Common Stock on the Principal Market or
another Eligible Market.


 






    13


     


    

 


4.4 Form
D and Blue Sky. The Company shall file a Form D with respect to the Securities as required under Regulation D and to provide a copy
thereof to the Subscribers. The Company shall, on or before the Closing Date, take such action as the Company shall reasonably determine
is necessary in order to obtain an exemption for, or to, qualify the Securities for sale to the Subscribers at the Closing pursuant to
this Agreement under applicable securities or “Blue Sky” laws of the states of the United States (or to obtain an exemption
from such qualification), and shall provide evidence of any such action so taken to the Subscribers on or prior to the Closing Date. Without
limiting any other obligation of the Company under this Agreement, the Company shall timely make all filings and reports relating to the
offer and sale of the Securities required under all applicable securities laws (including, without limitation, all applicable federal
securities laws and all applicable “Blue Sky” laws), and the Company shall comply with all applicable federal, state and local
laws, statutes, rules, regulations and the like relating to the offering and sale of the Securities to the Subscribers.


 


4.5 Indemnification.
In consideration of each Subscriber’s execution and delivery of the Transaction Documents and acquiring the Securities thereunder and
in addition to all of the Company’s other obligations under the Transaction Documents, the Company shall defend, protect, indemnify and
hold harmless each Subscriber and each other holder of the Securities and all of their shareholders, partners, members, officers, directors,
employees and direct or indirect investors and any of the foregoing Persons’ agents or other representatives (including, without limitation,
those retained in connection with the transactions contemplated by this Agreement) (collectively, the “Indemnitees”)
from and against any and all actions, causes of action, suits, claims, losses, costs, penalties, fees, liabilities and damages, and expenses
in connection therewith (irrespective of whether any such Indemnitee is a party to the action for which indemnification hereunder is sought),
and including reasonable attorneys’ fees and disbursements (the “Indemnified Liabilities”), incurred by any Indemnitee
as a result of, or arising out of, or relating to (a) any misrepresentation or breach of any representation or warranty made by the
Company in the Transaction Documents or any other certificate, instrument or document contemplated hereby or thereby, (b) any breach
of any covenant, agreement or obligation of the Company contained in the Transaction Documents or any other certificate, instrument or
document contemplated hereby or thereby or (c) any cause of action, suit or claim brought or made against such Indemnitee by a third party
(including for these purposes a derivative action brought on behalf of the Company) and arising out of or resulting from (i) the
execution, delivery, performance or enforcement of the Transaction Documents or any other certificate, instrument or document contemplated
hereby or thereby, (ii) any transaction financed or to be financed in whole or in part, directly or indirectly, with the proceeds of the
issuance of the Securities, or (iii) the status of such Subscriber or holder of the Securities as an investor in the Company pursuant
to the transactions contemplated by the Transaction Documents, in each case of the foregoing subclauses (i) through (iii) except solely
to the extent arising from any misrepresentation or breach of any representation or warranty made by such Subscriber in the Transaction
Documents, or any bad faith, gross negligence or willful misconduct of such Subscriber. For the avoidance of doubt, clauses (a) and (b)
of the preceding sentence are intended to apply, and shall apply, to direct claims asserted by any Subscriber against the Company as well
as any third party claims asserted by an Indemnitee (other than a Subscriber) against the Company. To the extent that the foregoing undertaking
by the Company may be unenforceable for any reason, the Company shall make the maximum contribution to the payment and satisfaction of
each of the Indemnified Liabilities which is permissible under applicable law. To the extent that the foregoing undertaking by the Company
may be unenforceable for any reason, the Company shall make the maximum contribution to the payment and satisfaction of each of the Indemnified
Liabilities that is permissible under applicable law. Except as otherwise set forth herein, the mechanics and procedures with respect
to the rights and obligations under this Section 4.5 shall be the same as those set forth in Section 6 of the Registration Rights
Agreement.


 






    14


     


    

 


4.6 Reporting
Status; Financial Information. Until the earlier of (i) the date on which the Subscriber shall have sold all of the Securities and
(ii) such date on which the Company is acquired, is liquidated or completes a going private transaction in a transaction where the Common
Stock is no longer outstanding (the “Reporting Period”), the Company shall use reasonable best efforts to timely file
all reports required to be filed with the SEC pursuant to the 1934 Act, and the Company shall not terminate its status as an issuer required
to file reports under the 1934 Act even if the 1934 Act or the rules and regulations thereunder would no longer require or otherwise permit
such termination. The Company agrees to send the following to each Subscriber during the Reporting Period: (i) unless the following
are filed with the SEC through EDGAR and are available to the public through the EDGAR system, within one (1) Business Day after the filing
thereof with the SEC, a copy of its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, any interim reports or any consolidated
balance sheets, income statements, shareholders’ equity statements and/or cash flow statements for any period other than annual, any Current
Reports on Form 8-K and any registration statements (other than on Form S-8) or amendments filed pursuant to the 1933 Act, (ii) unless
the following are either filed with the SEC through EDGAR or are otherwise widely disseminated via a recognized news release service (such
as PR Newswire), on the same day as the release thereof, facsimile copies of all press releases issued by the Company or any of its Subsidiaries
and (iii) unless the following are filed with the SEC through EDGAR, copies of any notices and other information made available or
given to the shareholders of the Company generally, contemporaneously with the making available or giving thereof to the shareholders.


 


ARTICLE
V.

CLOSING DELIVERABLES


 


5.1 Closing
Deliverables of the Company. At the Closing, the Company shall deliver to the Subscribers the following:


 


(a) Officer’s
Certificate. The representations and warranties of the Company shall be true and correct in all respects as of the date when made
and as of the Closing Date as though made at that time (except for representations and warranties that speak as of a specific date which
shall be true and correct as of such specified date) and the Company shall have performed, satisfied and complied in all respects with
the covenants, agreements and conditions required by the Transaction Documents to be performed, satisfied or complied with by the Company
at or prior to the Closing Date. Such Subscriber shall have received a certificate, executed by the Chief Executive Officer of the Company,
dated as of the Closing Date, to the foregoing effect in the form attached hereto as Exhibit C.


 


(b) Secretary’s
Certificate. Such Subscriber shall have received a certificate, executed by the Secretary of the Company, dated as of the Closing
Date, to (w) the resolutions consistent with Section 3.1(a) as adopted by the Company’s Board of Directors in a form reasonably acceptable
to such Subscriber, (x) the Company’s Certificate of Incorporation, (y) the Company’s Bylaws and (z) the incumbency and specimen signature
of each officer of the Company who may sign this Agreement and the other Transaction Documents, and as to such other matters as may be
reasonably requested by such Subscriber in the form attached hereto as Exhibit D.


 


(c) Transaction
Documents. The Company shall have duly executed and delivered to such Subscriber (A) each of the Transaction Documents and (B)
such Warrants (for such aggregate number of shares of Common Stock as is set forth across from such Subscriber’s name in column (3) of
the Schedule of Subscribers).


 


(d) Legal
Opinion. Such Subscriber shall have received the opinion of Greenberg Traurig, LLP, the Company’s outside counsel, dated as of the
Closing Date, in the form attached hereto as Exhibit E.


 






    15


     


    

 


ARTICLE
VI.

MISCELLANEOUS


 


6.1 Fees
and Expenses. The Company shall reimburse Monroe or its designee(s) (in addition to any other expense amounts paid to any Subscriber
prior to the date of this Agreement) for all reasonable actual costs and expenses incurred in connection with the transactions contemplated
by the Transaction Documents (including all reasonable legal fees and disbursements in connection therewith and documentation and implementation
of the transactions contemplated by the Transaction Documents) on or prior to the Closing, which amount shall be paid by the Company at
the Closing. The Company shall pay, and hold each Subscriber harmless against, any liability, loss or expense (including, without limitation,
reasonable attorney’s fees and out-of-pocket expenses) arising in connection with any claim relating to any payment, including, without
limitation, any placement agent’s fees, financial advisory fees, or broker’s commissions (other than for any Persons engaged by any Subscriber)
relating to or arising out of the transactions contemplated hereby. Except as otherwise set forth in the Transaction Documents, each party
to this Agreement shall bear its own expenses in connection with the sale of the Securities to the Subscribers.


 


6.2 Entire
Agreement; Amendments. This Agreement and the other Transaction Documents supersede all other prior oral or written agreements between
the Subscribers, the Company, their Affiliates and Persons acting on their behalf with respect to the matters discussed herein, and this
Agreement and the other Transaction Documents contain the entire understanding of the parties with respect to the matters covered herein
and therein and, except as specifically set forth herein or therein, neither the Company nor any Subscriber makes any representation,
warranty, covenant or undertaking with respect to such matters. No provision of this Agreement may be amended other than by an instrument
in writing signed by the Company and the Required Holders, and any amendment to this Agreement made in conformity with the provisions
of this Section 6.2 shall be binding on all Subscribers and holders of Securities. No provision hereof may be waived other than
by an instrument in writing signed by the party against whom enforcement is sought. No such amendment shall be effective to the extent
that it applies to less than all of the holders of the applicable Securities then outstanding. The Company has not, directly or indirectly,
made any agreements with any Subscribers relating to the terms or conditions of the transactions contemplated by the Transaction Documents
except as set forth in the Transaction Documents. Without limiting the foregoing, the Company confirms that, except as set forth in this
Agreement and the Financing Agreement, no Subscriber has made any commitment or promise or has any other obligation to provide any financing
to the Company or otherwise. No consideration shall be offered or paid to any Person to amend or consent to a waiver or modification of
any provision of any of the Transaction Documents unless the same consideration (other than the reimbursement of legal fees) also is offered
to all of the parties to the Transaction Documents or holders of the Warrants, as the case may be.


 






    16


     


    

 


6.3 Notices.
Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be in
writing and will be deemed to have been delivered: (i) upon delivery, when delivered personally; (ii) upon delivery, when sent by electronic
mail (provided that the sending party does not receive an automated rejection notice) or (iii) one (1) Business Day after deposit with
a nationally recognized overnight delivery service, in each case properly addressed to the party to receive the same. The addresses and
email addresses for such communications shall be:


 


	If to the Company:	American Virtual Cloud Technologies, Inc.
	 	1720 Peachtree Street, Suite 629
	 	Atlanta, GA 30309
	 	Telephone: 	(404) 769-3236
	 	Attention:	Chief Financial Officer
	 	Email:	tking@avctechnologies.com



 


	With a copy (for information purposes only) to:	Greenberg Traurig, LLP
	 	1750 Tysons Boulevard, Suite 1000
	 	McLean, VA 22102
	 	Telephone: 	(703) 749-1386
	 	Attention:	Jason Simon, Esq.
	 	Email:	simonj@gtlaw.com



 


	If to the Transfer Agent:	Continental Stock Transfer & Trust Company
	 	1 State Street, 30th Floor
	 	New York, NY 10004]
	 	Telephone:   	(212) 845-3285
	 	Attention:  	Richard Viscovich
	 	Email:  	rviscovich@continentalstock.com
	 	 	 
	If to a Subscriber:	To its address, email and number set forth on the Schedule of Subscribers,
with copies to such Subscriber’s representatives as set forth on the Schedule of Subscribers.



 


	With a copy (for information purposes only) to:	Schulte Roth & Zabel LLP
	 	919 Third Avenue
	 	New York, NY 10022
	 	Telephone: 	 (212) 756-2008
	 	Attention: 	 Chris Bell, Esq.
	 	Email:	Chris.Bell@srz.com



 


or such other address as may
be designated in writing hereafter, in the same manner, by such Person by two (2) Business Days’ prior notice to the other party in accordance
with this Section 6.3. Written confirmation of receipt (A) given by the recipient of such notice, consent, waiver or other
communication, (B) electronically generated by the sender’s email transmission containing the time, date, recipient e-mail address or
(C) provided by a courier or overnight courier service shall be rebuttable evidence of personal service, receipt by email or receipt from
a nationally recognized overnight delivery service in accordance with clause (i), (ii) or (iii) above, respectively.


 






    17


     


    

 


6.4 Construction.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
of the provisions hereof. No specific representation or warranty shall limit the generality or applicability of a more general representation
or warranty. The parties agree that each of them and/or their respective counsel has reviewed and had an opportunity to revise the Transaction
Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party
shall not be employed in the interpretation of the Transaction Documents or any amendments hereto.


 


6.5 Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.
The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of the Subscribers.
Any Subscriber may assign its rights under this Agreement to any Person to whom such Subscriber assigns or transfers any Securities, provided
such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions hereof and of the applicable
Transaction Documents that apply to the “Subscribers.” Notwithstanding anything to the contrary herein, Securities may be pledged
to any Person in connection with a bona fide margin account or other loan or financing arrangement secured by such Securities.


 


6.6 No
Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted
assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except that each Indemnitee is an
intended third party beneficiary of Section 4.5 and may enforce the provisions of such Sections directly against the parties
with obligations thereunder.


 


6.7 Governing
Law; Venue; Process Agent; Waiver of Jury Trial. All questions concerning the construction, validity, enforcement and interpretation
of this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of New York (except
for matters governed by corporate law in the State of Delaware), without regard to the principles of conflicts of law thereof. Each party
agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this agreement
(whether brought against a party hereto or its respective Affiliates, directors, officers, shareholders, employees or agents) shall be
commenced exclusively in the state and federal courts sitting in the City of New York, Borough of Manhattan. Each party hereto hereby
irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan
for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein
(including with respect to the enforcement of this Agreement). Each party hereto hereby irrevocably waives personal service of process
and consents to process being served in any such Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery
(with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service
shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way
any right to serve process in any manner permitted by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES
NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT OR ANY
TRANSACTION CONTEMPLATED HEREBY.


 


6.8 Survival.
The representations, warranties, agreements and covenants contained herein shall survive the Closing and the delivery and/or exercise
of the Securities, as applicable.


 






    18


     


    

 


6.9 Execution.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that
both parties need not sign the same counterpart. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic
signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any counterpart
so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.


 


6.10 Severability.
If any provision of this Agreement is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent
jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest
extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity
of the remaining provisions of this Agreement so long as this Agreement as so modified continues to express, without material change,
the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the
provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical
realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to
replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible
to that of the prohibited, invalid or unenforceable provision(s).


 


6.11 Rescission
and Withdrawal Right. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) the Transaction
Documents, whenever any Subscriber exercises a right, election, demand or option under a Transaction Document and the Company does not
timely perform its related obligations within the periods therein provided, then such Subscriber may rescind or withdraw, in its sole
discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice
to its future actions and rights.


 


6.12 Remedies.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Subscribers
and the Company will be entitled to specific performance under the Transaction Documents. Any Person having any rights under any provision
of this Agreement shall be entitled to enforce such rights specifically (without posting a bond or other security), to recover damages
by reason of any breach of any provision of this Agreement and to exercise all other rights granted by law. Furthermore, the Company recognizes
that in the event that it fails to perform, observe, or discharge any or all of its obligations under the Transaction Documents, any remedy
at law may prove to be inadequate relief to the Subscribers. The Company therefore agrees that the Subscribers shall be entitled to seek
specific performance and/or temporary, preliminary and permanent injunctive or other equitable relief from any court of competent jurisdiction
in any such case without the necessity of proving actual damages and without posting a bond or other security.


 


6.13 Payment
Set Aside. To the extent that the Company makes a payment or payments to any Subscriber hereunder or pursuant to any of the other
Transaction Documents or any Subscriber enforces or exercises its rights hereunder or thereunder, and such payment or payments or the
proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential,
set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company or any Subsidiary
by a trustee, receiver or any other person under any law (including, without limitation, any bankruptcy law, state or federal law, common
law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be
satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had
not occurred.


 






    19


     


    

 


6.14 Further
Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute
and deliver all such other agreements, certificates, instruments and documents, as any other party may reasonably request in order to
carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.


 


6.15 Replacement
of Securities. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall
issue or cause to be issued in exchange and substitution for and upon cancellation thereof, or in lieu of and substitution therefor, a
new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction
and customary and reasonable indemnity, if requested. The applicants for a new certificate or instrument under such circumstances shall
also pay any reasonable third-party costs associated with the issuance of such replacement Securities.


 


6.16 Payments.
Whenever any payment of cash is to be made by the Company to any Person pursuant to the Transaction Documents, such payment shall be made
in lawful money of the United States via wire transfer of immediately available funds by providing the Company with prior written notice
setting out such request and such Subscriber’s wire transfer instructions; provided that such Subscriber may elect to receive a payment
of cash by a check drawn on the account of the Company and sent via overnight courier service to such Person at such address as previously
provided to the Company in writing (which address, in the case of each of the Subscribers, shall initially be as set forth on the Schedule
of Subscribers attached to the Subscription Agreement). Whenever any amount expressed to be due by the terms of this Warrant is due
on any day which is not a Business Day, the same shall instead be due on the next succeeding day which is a Business Day.


 


[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE PAGES FOLLOW]


 






    20


     


    

 

 


IN WITNESS WHEREOF,
each Subscriber and the Company have caused their respective signature page to this Agreement to be duly executed as of the date first
written above.


 


	 	COMPANY:
	 	 
	 	American Virtual Cloud Technologies, Inc.
	 	 
	 	By:	/s/ Thomas H. King
	 	 	Name: 	Thomas H. King
	 	 	Title: 	Chief Financial Officer and Secretary



 


[Signature
Page to Subscription Agreement]


 






    21


     


    

 


IN WITNESS WHEREOF,
each Subscriber and the Company have caused their respective signature page to this Agreement to be duly executed as of the date first
written above.


 


	 	MONROE CAPITAL INCOME PLUS CORPORATION
	 	 	 	 
	 	By:	/s/ Joseph P. Valickus
	 	 	Name: 	Joseph P. Valickus
	 	 	Title: 	Director



 


	 	Maximum Percentage to be included in the Warrants:
	 	  ☒	4.99%
	 	  ☐	9.99%



 


	 	MONROE CAPITAL private credit master fund iv scsp
	 	 	 
	 	By:	Monroe Capital Management
    Advisors LLC, as Investment Manager



 


	 	By:	/s/ Joseph P. Valickus
	 	 	Name: 	Joseph P. Valickus
	 	 	Title: 	Director



 





	 	Maximum Percentage to be included in the Warrants:
	 	  ☒	4.99%
	 	  ☐	9.99%


 





	 	MONROE CAPITAL private credit master fund iv (UNLEVERAGED) scsp
	 	 	 
	 	By:	Monroe Capital Management
    Advisors LLC, 
	 	as Investment Manager


 





	 	By:	/s/ Joseph P. Valickus
	 	 	Name: 	Joseph P. Valickus
	 	 	Title: 	Director


 





	 	Maximum Percentage to be included in the Warrants:
	 	  ☒	4.99%
	 	  ☐	9.99%


 






    22


     


    

 


	 	MONROE PRIVATE CREDIT FUND A LP
	 	 	 
	 	By:	Monroe Private Credit Fund A LLC, its
	 	general partner


 


	 	By:	/s/ Joseph P. Valickus
	 	 	Name: 	Joseph P. Valickus
	 	 	Title: 	Director


 





	 	Maximum Percentage to be included in the Warrants:
	 	  ☒	4.99%
	 	  ☐	9.99%


 


	 	MONROE CAPITAL Opportunistic private credit master fund scsp
	 	 	 
	 	By:	Monroe Capital Management Advisors LLC, 
	 	as Investment Manager


 


	 	By:	/s/ Joseph P. Valickus
	 	 	Name: 	Joseph P. Valickus
	 	 	Title: 	Director



 





	 	Maximum Percentage to be included in the Warrants:
	 	  ☒	4.99%
	 	  ☐	9.99%


 


	 	MONROE CAPITAL private credit fund 559 lp
	 	 	 
	 	By:	Monroe Capital Private Credit Fund 559 GP 
	 	LLC, its general partner


 


	 	By:	/s/ Joseph P. Valickus
	 	 	Name: 	Joseph P. Valickus
	 	 	Title: 	Director



 





	 	Maximum Percentage to be included in the Warrants:
	 	  ☒	4.99%
	 	  ☐	9.99%


 


[Signature
Page to Subscription Agreement]


 


 


23